The program is aimed at funding 30 investigators seeking to develop assays that can be miniaturized, automated, and used for screening small molecules.
The institute plans to fund development of new technologies for understanding NHP major histocompatibility complex genes for use in research that could apply to humans.
The startup will use the funds to support a pivotal clinical study designed to obtain US Food and Drug Administration clearance for its iNOS sepsis test.
The funding will support the creation of biorepositories, biomarker discovery and validation, and personalized cancer therapeutic clinical trials.
The NCI and NIA will provide support for research into the mammalian target of rapamycin signaling network, which may play an important role in healthy aging.
Scientists from the company and JHU will use a $340,000 NCI grant to test metabolomic pathways as indicators of lung cancer therapeutic resistance.
The Early Career Development Award will fund studies into gene expression controls in corn and aims to engage students in all aspects of lab research.
Three grant types will support clinical, basic, and applied research using genomic and pharmacogenomic approaches, among others.
The small grants will fund biomarker studies, molecular science, and diagnostic research into immunodeficiency diseases.
A new grant program aims to encourage the combination of quantitative and physical science with biomedicine to develop biomarkers and other new technologies.
The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.
60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.
In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.
GenomeWeb reports that Veritas Genetics is suspending its US operations.